Delivery Order SPE2DB22D9101-SPE2DB24FU7KK
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the pharmaceutical product EXPAREL 266 MG/20 ML VIAL 20ML, with a potential value of $9,948.88 and a completion date of January 29, 2024. DMS Pharmaceutical Group holds a variety of federal contracts and indefinite delivery vehicles with DLA to supply pharmaceuticals and medical products in support of military treatment...
- The Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of EXPAREL 133 MG/10 ML VIAL 10ML. The delivery order, valued at $5,711.28, has a completion date of May 30, 2024 and was awarded on May 8, 2024. DMS Pharmaceutical Group holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued up to $499,999,999, that allows the agency to issue delivery orders for...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product EXPAREL 133 MG/10 ML VIAL 10ML. The order has a potential value of $8,566.92 and a completion date of January 29, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that holds various federal contracts and indefinite delivery vehicles to supply pharmaceuticals and medical products to the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,507.22 contract is for the delivery of EXPAREL 133 MG/10 ML VIAL 10ML, a pharmaceutical product, with a period of performance through April 2, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue firm...
- This firm fixed-price delivery order, awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, provides for the purchase of EXPAREL 266 MG/20 ML VIAL 20ML. The order, valued at $9,948.88, has a completion date of July 25, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The $27,404.34 delivery order is for the pharmaceutical product EXPAREL 133 MG/10 ML VIAL 10ML. The order has a completion date of February 5, 2024 and was awarded on January 12, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract with DLA to provide a variety of pharmaceutical and...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $7,531.89 contract is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML, with a completion date of July 31, 2025. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler that specializes in providing a range of medical products, including prescription drugs, to federal agencies. The company holds a significant single-award...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the supply of EXPAREL 266 MG/20 ML VIAL 20ML pharmaceutical products, with a potential value of $149,286.60. The order has a completion date of February 16, 2023 and was awarded on January 26, 2023. DMS Pharmaceutical Group holds a variety of federal contracts and indefinite delivery vehicles (IDVs) to supply pharmaceuticals and...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $2,291.36 order is for the supply of EXPAREL 133 MG/10 ML VIAL 10ML pharmaceutical products. The award is part of a larger DLA medical supply contract vehicle, with a ceiling value of up to $499,999,999, that allows the agency to issue delivery orders for a wide range of pharmaceutical items to support military...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,531.89, is for the delivery of EXPAREL 266 MG/20 ML VIAL 20ML, a pharmaceutical product. The delivery order has a completion date of May 9, 2025 and was awarded on April 18, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery...
- SPE2DB22D9101Indefinite Delivery Contract
- SPE2DB22D9101-SPE2DB24FU7KKDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of EXPAREL 133 MG/10 ML VIAL 10ML, with a potential value of $2,291.36. The order has a completion date of February 12, 2024 and was awarded on January 22, 2024. DMS Pharmaceutical Group is an established pharmaceutical wholesaler that holds multiple contracts and indefinite delivery vehicles (IDVs) with DLA to provide a wide range of pharmaceutical and medical supplies in support of military treatment facilities worldwide. This delivery order is issued against one of DMS Pharmaceutical Group's existing IDV contracts with DLA to procure necessary pharmaceutical items on a firm fixed price basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 1/22/24 |